US Patent Issued to Chengdu FANXI Biopharma on Jan. 13 for "Substituted benzimidazole derivative and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,569, issued on Jan. 13, was assigned to Chengdu FANXI Biopharma Co. Ltd. (China).

"Substituted benzimidazole derivative and use thereof" was invented by Niefang Yu (Sichuan, China), Xin Chen (Sichuan, China), Hao Li (Sichuan, China) and Xiaoyu Liu (Sichuan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a substituted benzimidazole derivative as represented by formula (I) and a pharmaceutically acceptable salt, a polymorph, a tautomer, a stereoisomer, a hydrate, a solvate or an isotopic variant of the derivative. The compound is a PPAR Alpha and/or PPAR Delta agonist, therefore the compound can be used for treat...